WallStreetZenWallStreetZen

NASDAQ: ITRM
Iterum Therapeutics PLC Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

ITRM past revenue growth

How has ITRM's revenue growth performed historically?
Company
N/A
Industry
148.97%
Market
17.57%
ITRM's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
ITRM's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance

ITRM earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$38.4M
Current Profit Margin
0%

ITRM Return on Equity

Current Company
-664%
Current Industry
-63.5%
Current Market
188%
ITRM's Return on Equity (-664%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when ITRM announces earnings.

ITRM Return on Assets

Current Company
-87.6%
Current Industry
2.9%
ITRM is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

ITRM Return on Capital Employed

Current Company
-285.14%
Current Industry
19.5%
ITRM's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ITRM vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
ITRM$0.00-$34.58M-$38.37M-100.00%N/A
SLGL$1.55M-$26.90M-$27.24M+64.50%N/A
GDTC$0.00-$2.80M-$3.18MN/AN/A
AIM$202.00k-$28.44M-$28.96M-11.26%N/A
CERO$0.00-$2.44M-$2.54MN/AN/A
View Top Biotech Stocks

ITRM earnings dates

Next earnings date
May 10, 2024

Iterum Therapeutics Earnings & Revenue FAQ

What were ITRM's earnings last quarter?

On Invalid Date, Iterum Therapeutics (NASDAQ: ITRM) reported Q4 2023 earnings per share (EPS) of -$0.94, up 129.27% year over year. Total Iterum Therapeutics earnings for the quarter were -$12.36 million. In the same quarter last year, Iterum Therapeutics's earnings per share (EPS) was -$0.41.

If you're new to stock investing, here's how to buy Iterum Therapeutics stock.

What was ITRM's earnings growth in the past year?

As of Q2 2024, Iterum Therapeutics's earnings has grown year over year. Iterum Therapeutics's earnings in the past year totalled -$38.37 million.

What is ITRM's earnings date?

Iterum Therapeutics's earnings date is Invalid Date. Add ITRM to your watchlist to be reminded of ITRM's next earnings announcement.

What was ITRM's revenue last quarter?

On Invalid Date, Iterum Therapeutics (NASDAQ: ITRM) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Iterum Therapeutics's revenue was $0.00.

What was ITRM's revenue growth in the past year?

As of Q2 2024, Iterum Therapeutics's revenue has grown null year over year. Iterum Therapeutics's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.